E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Phase 1/2 Completed
224 enrolled 15 charts
APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
Phase 3 Completed
1,428 enrolled 21 charts
Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy
Phase 3 Completed
401 enrolled 14 charts
Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP
Phase NA Withdrawn
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
Phase 1 Withdrawn
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years
Phase 1 Withdrawn
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years
Phase 1 Completed
19 enrolled
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC
Phase 3 Unknown
300 enrolled
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Phase 3 Completed
76 enrolled 8 charts
Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients
Phase NA Unknown
120 enrolled
Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer
Phase 1 Completed
33 enrolled
KMEC
Phase 4 Completed
494 enrolled 14 charts
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Phase NA Terminated
4 enrolled 5 charts
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Phase 2 Completed
36 enrolled 12 charts
Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy
Phase 1 Terminated
29 enrolled
PEGAZUS
Phase 4 Completed
21 enrolled
Treatment Algorithm for Nausea and Vomiting in the Palliative Phase
Phase 4 Unknown
20 enrolled
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Phase NA Completed
40 enrolled 9 charts
Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers
Phase 1 Completed
50 enrolled
The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy
Phase 2 Completed
92 enrolled
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
Phase 2 Completed
22 enrolled 9 charts
Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial
Phase 3 Completed
1,021 enrolled 10 charts
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
Phase 2 Completed
700 enrolled
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
Phase 3 Completed
Randomized Crossover Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Granisetron in Cancer Patients
Phase 2 Completed
31 enrolled
Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation
Phase 3 Completed
100 enrolled
Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients
Phase 2 Withdrawn
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
Phase 3 Unknown
Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
Phase 3 Unknown
150 enrolled
Drugs to Reduce the Side Effects of Chemotherapy
Phase 3 Completed
267 enrolled
AMENO-2
Phase 4 Completed
196 enrolled
An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients
Phase 2 Completed
208 enrolled